Morpholine → (S)-Methyl 1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-6-morpholino-1,3,5-triazin-2-yl)-2,4,4-trimethylpyrrolidine-2-carboxylate
Reaction equation
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.Cl[C:8]1[N:13]=[C:12]([NH:14][C:15]2[CH:19]=[C:18]([CH:20]3[CH2:22][CH2:21]3)[NH:17][N:16]=2)[N:11]=[C:10]([N:23]2[CH2:27][C:26]([CH3:29])([CH3:28])[CH2:25][C@@:24]2([CH3:34])[C:30]([O:32][CH3:33])=[O:31])[N:9]=1>>[CH:20]1([C:18]2[NH:17][N:16]=[C:15]([NH:14][C:12]3[N:13]=[C:8]([N:1]4[CH2:6][CH2:5][O:4][CH2:3][CH2:2]4)[N:9]=[C:10]([N:23]4[CH2:27][C:26]([CH3:28])([CH3:29])[CH2:25][C@@:24]4([CH3:34])[C:30]([O:32][CH3:33])=[O:31])[N:11]=3)[CH:19]=2)[CH2:22][CH2:21]1Participants
3
Reactant 2
Product 1
Procedure
Compound 106F was prepared from morpholine and 106E as described for 1: LC/MS [M+H]+: 457; Ret time (Method F): 2.97 min.
Workup
- custom2.97 min.
Sources & evidence
- ORD record
- ord-63c9ed5e50a748bdbdff54309fd351f5
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08415340B2
Reaction notes
Loading…